Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Sniecinski Megan received 21 Praxis Precision Medicines, Inc. shares as an award (Form 4)
Traded Nov 13, 2026 · Filed Nov 18, 2026
On Nov 13, 2026, Sniecinski Megan (Chief Operating Officer) received 21 Praxis Precision Medicines, Inc. shares as an award at US$278.91 for US$5,857, leaving 28,685 shares. Filed Nov 18, 2026 (Form 4).
- Awarded
- 21 shares
- Price
- US$278.91
- Value
- US$5,857
- Holding after
- 28,685 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common Stock | Award | 21 | US$278.91 | 28,685 | Direct |
Source
Download original · View original at SEC
Related
- Praxis Precision Medicines, Inc.
- Sniecinski Megan
- Praxis Precision Medicines, Inc. shareholders
- Form 4 · Sniecinski Megan · May 19, 2026
- Form 4 · Nemiroff Alex · Nov 18, 2026
- Form 4 · Kelly Timothy Edwin · Nov 18, 2026
- Form 4 · Mastrocola Lauren · Nov 18, 2026
- Schedule 13G/A · Orbis Investment Management LTD · Nov 16, 2026
- Schedule 13G/A · FMR LLC · Nov 5, 2026